| Sep 25, 2011
| 8:41 AM
STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday.
| Sep 27, 2011
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
Doctors in the...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
| Sep 13, 2011
| 8:24 AM
LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
| Nov 24, 2011
| 12:41 PM
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
The move underscores Gardasil's lead in a $1 billion-plus worldwide...
| Jun 16, 2011
| 4:39 PM
Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2).
Yes, I know, they are big sellers, and make money for the merchants....
| Jun 13, 2011
| 3:01 AM
In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...
| Feb 20, 2013
| 3:50 PM
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
The company also withheld data that showed the drugs...
| Mar 19, 2013
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines.
Today, as the world confronts the crisis of antibiotic resistance, the industry...
| Jun 8, 2012
| 1:54 PM
Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion.
Ripley Entertainment Inc. said exhibits at the Inner Harbor...
| Jul 2, 2012
| 10:35 AM
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...